Digital Content

Event Global

Footer

2023 Event

Event Global Footer

Startup Opportunities

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu

HEP Strategic Investing Summit: Executive Playbook

The last ten years have seen an explosion of health systems and health plan-based venture and innovation funds. The acceleration of digital adoption throughout COVID, the migration to new payment models, a rapidly consolidating competitive landscape, and the incursions of big tech and retail into healthcare have led many payers and providers to aggressively seek opportunities “outside the core” for growth. Ezra Mehlman, a healthcare growth equity investor and professor at Columbia Business School, will organize a discussion for hospital and health plan senior executives who are interested in standing up and operating strategic venture funds. The summit will feature a panel showcasing the perspectives of leading strategic VCs as well as venture-backed companies who have raised money from strategic funds.

The last ten years have seen an explosion of health systems and health plan-based venture and innovation funds. The acceleration of digital adoption throughout COVID, the migration to new payment models, a rapidly consolidating competitive landscape, and the incursions of big tech and retail into healthcare have led many payers and providers to aggressively seek opportunities “outside the core” for growth. Ezra Mehlman, a healthcare growth equity investor and professor at Columbia Business School, will organize a discussion for hospital and health plan senior executives who are interested in standing up and operating strategic venture funds. In the course of the examination, we will:- Evaluate the universe of options accessible to CEOs interested in launching such investment groups- Draw upon the best practices and perspectives of systems who have operated strategic venture funds–as well as hone in on the myriad pitfalls to avoid in standing one up- Conduct a deep dive of how strategic investing fits into the broader healthcare PE and VC landscape,- Review approaches towards valuing early-stage healthcare companies, term sheet basics, investment process and due diligence management, and how to be a good strategic customer-investor partner to your portfolio companies- Offer a set of reflections on the shifting capital markets in HCIT—and the implications for startups, and leaders of venture funds The summit will feature a panel showcasing the perspectives of leading strategic VCs as well as venture-backed companies who have raised money from strategic funds. Speakers:<ul><li>Spence McClelland, Partner, Noro-Moseley Ventures</li><li>Leah Sparks, CEO, Wildflower Health</li><li>Jeff Stolte, Senior Partner, Providence Ventures</li><li>Jessica Zeaske, Partner, Echo Health Ventures</li></ul>

Partner Programs

Digital Therapeutics: An Industry is Growing up & Breaking Out!

Evercore ISI and Digital Therapeutics Alliance are pleased to host a variety of sessions to discuss key topics relevant to the ever-changing DTx Landscape inclusive of providers, payors, and pharma companies, both domestically and overseas. Our high-profile speakers are here to share their insights and advice as it relates to regulation and reimbursement, commercialization, and value-add partnerships

Evercore ISI serves more than 1,300 institutional investors globally, representing the largest asset managers and fund complexes in the world. At Evercore ISI, our experienced Research, Sales and Trading professionals deliver superior client service on a content-led platform. Every day, we strive to be The Street’s best investment research resource to support our clients’ overall money management needs.

Moving the Needle on Commercial Reimbursement

One of the key ongoing challenges that DTx faces is attaining coverage from payors; during our first session, we hope to shed light on what payors are looking for clinically and economically (hint: it&#39;s evidence). Moderator: <a href="https://www.linkedin.com/in/jessica-hauflaire-51063b33/" target="_blank" style="color: rgb(6, 23, 234);">Jessica Hauflaire</a>, COO, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/julia-m-strandberg/" target="_blank" style="color: rgb(6, 33, 231);">Julia Strandberg</a>, Chief Commercial Officer, Pear Therapeutics<a href="https://www.linkedin.com/in/josephperekupka/" target="_blank" style="color: rgb(6, 33, 231);">Joe Perekupka</a>, CEO, Freespira <a href="https://www.linkedin.com/in/jason-parent-msn-aprn-fnp-c-3978a71a" target="_blank" style="color: rgb(6, 33, 231);">Jason Parent</a>, Director, Clinical Innovation, Point32Health

DTx in Capitol Hill

In September, our esteemed colleagues at DTA held a Capitol Hill Advocacy Event to promote awareness and discuss policies and legislation that provide better access and coverage to DTx. Today, they share what they took away from those meetings and discuss the relevance of the Access to Prescription Digital Therapeutics Act of 2022. Moderator: <a href="https://www.linkedin.com/in/andy-molnar/" target="_blank" style="color: rgb(6, 23, 234);">Andy Molnar</a>, CEO, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/liesloldstone/" target="_blank" style="color: rgb(6, 23, 234);">Liesl Oldstone</a>, VP, Health Economics and Market Access, AppliedVR<a href="https://www.linkedin.com/in/everett-crosland-018aba13/" target="_blank" style="color: rgb(6, 23, 234);">Everett Crosland,</a> Chief Commercial Officer, Cognito Therapeutics

DTx: International Landscape

While the US is an early adopter of DTx, we can learn much from earlier pioneers and their success stories overseas. Our panelists hope to share their insights as to what is and isn&#39;t working internationally. Moderator: <a href="https://www.linkedin.com/in/megan-coder-a10444b/" target="_blank" style="color: rgb(6, 23, 234);">Megan Coder</a>, Chief Policy Officer, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/hanneskloepper/" target="_blank" style="color: rgb(6, 23, 234);">Hannes Klopper,</a> CEO, HelloBetter <a href="https://www.linkedin.com/in/jydkim/" target="_blank" style="color: rgb(6, 23, 234);">Danny Kim</a>, Head of WELT USA, WELT

Making Your DTx Product Launch a Success the First Time

With the industry still in its early stages, there hasn&#39;t been a playbook for success...until now! With DTA&#39;s recently developed Product Launch Playbook, we bring together key experts who have and continue to navigate their way through their respective product launches. Moderator: <a href="https://www.linkedin.com/in/lani-hessen-otr-l-462a881/" target="_blank" style="color: rgb(6, 23, 234);">Lani Hessen</a>, VP, Patient Access, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/jennifer-lavanture-18110a21/" target="_blank" style="color: rgb(6, 23, 234);">Jennifer Lavanture</a>, VP of Business Development, MedRhythms<a href="https://www.linkedin.com/in/sarahtraffordkoenig/" target="_blank" style="color: rgb(6, 23, 234);">Sarah Koenig</a>, Senior Director and Head of Marketing, Freespira<a href="https://www.linkedin.com/in/vjbala" target="_blank" style="color: rgb(6, 23, 231);">VJ Bala</a>, Senior Vice President, Marketing, Propeller Health<a href="https://www.linkedin.com/in/katelynkreitzer/" target="_blank" style="color: rgb(6, 23, 234);">Katie Kreitzer,</a> Lead Content Designer, Limbix

Partnering with Pharma: What Works?

Pharmaceutical partnerships offering a variety of benefits including access to far greater resources, expertise, and commercial relationships. Listen in on what works when pursuing a partnership with pharmaceutical companies. Moderator: Elizabeth Anderson, Managing Director, Evercore ISISpeakers:Jorge Cancela, Digital Health Leader, RocheOfer Leidner, Co-Founder and President, TwillJason Hawbecker, Head of Strategic Partnerships, Biogen

Scaling Mental Health, But Not at All Costs

Going Digital: Behavioral Health Tech is the leading community and media business committed to expanding access to mental health and substance use services through technology and innovation. Our community is made up of health plans, employers, health systems, behavioral health providers, startups, investors and policymakers to connect for the purposes of advancing access to behavioral healthcare for all. We solve the inertia of access to quality behavioral healthcare by convening all stakeholders to develop, adopt and improve behavioral health tech and innovation.

The healthcare industry is grappling with how to address the dire mental health and substance use crisis. Funding has poured into behavioral health technology startups and innovations these last few years, but is it sustainable? Join us for a dedicated behavioral health program at HLTH with payors, providers, pharma, startups and investors to discuss how to scale behavioral health solutions. We will cover affordability, the provider crisis, how to decipher high-quality solutions through the noise, and measuring outcomes for patients.  Host: Solome Tibebu, Founder &amp; CEO, Going Digital 10:05am - 10:50am: How Health Plans Are Scaling Mental Health Innovation From The Outside InModerator: Shirley Bergin, former COO and Executive Director, TEDMED and current Chief Innovation Officer, Ellipsis HealthPanelists:Dr. Cara McNulty, DPA, President of Behavioral Health and Mental Wellbeing, CVS HealthEva Borden, President of Behavioral Health, EvernorthSuzanne Kunis, Vice President of Behavioral Health, Horizon Blue Cross Blue Shield of New Jersey 10:55am - 11:40am: What Role Does Pharma Have in Scaling Mental Health SafelyModerator: Dr. Murray Zucker, Medical Director, TwillPanelists: Dr. Satish Singh, Associate Director of Strategic Partnerships, BiogenJeff Weness, Head of Digital Opportunities and Investments, OtsukaSaad Shah, Head of Digital Health Technology Strategy &amp; Innovation Business Development Team, Amgen 11:45am - 12:25pm: The Venture Capitalists&#39; Perspective on Scaling Mental HealthModerator: Margaret Laws, Founder and CEO, HopelabPanelists:Laura Veroneau, Partner, Optum VenturesLiam Donohue, Partner, .406 VenturesObadiah Sang, Managing Director, Head of Corporate Development &amp; Strategic Investing, Independence Blue Cross 12:25pm - 1:00pm: Networking